Cover Image

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo

Saved in:

Bibliographic Details
Main Authors:	S.A. Watters (Author), M.N. Polizzotto (Author), W. Shao (Author), R. Gorelick (Author), E.M. Anderson (Author), I. Sereti (Author), K. Aleman (Author), L. Kouyoudjian (Author), J.B. Zeldis (Author), T. Uldrick (Author), R. Yarchoan (Author), F. Maldarelli (Author)
Format:	Book
Published:	Elsevier, 2016-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy
by: G. Bozzi, et al.
Published: (2016)

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues
by: F. Maldarelli, et al.
Published: (2019)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
by: Gowin KL, et al.
Published: (2015)

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
by: Rios-Tamayo R, et al.
Published: (2017)

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation
by: C. Lange, et al.
Published: (2019)

PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
by: M. Yu. Frolov, et al.
Published: (2017)

Distribution of pomalidomide into semen of healthy male subjects after multiple doses
by: Li Y, et al.
Published: (2018)

Synthesis and Anti-Tumor Effects of Novel Pomalidomide Derivatives Containing Urea Moieties
by: Yajie Guo, et al.
Published: (2022)

Pomalidomide enhances the maturation of dendritic cells derived from healthy donors and multiple myeloma patients
by: Xi Wang, et al.
Published: (2022)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients-Real-World Data From Hungary
by: Szilvia Lovas, et al.
Published: (2022)

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
by: Li Y, et al.
Published: (2017)

Interim safety analysis of cancer immunotherapy trials Network - 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer
by: T.S. Uldrick, et al.
Published: (2017)

Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
by: Núria Climent, et al.
Published: (2019)

Exposure‐response analyses for selection/confirmation of optimal isatuximab dosing regimen in combination with pomalidomide/dexamethasone treatment in patients with multiple myeloma
by: Fatiha Rachedi, et al.
Published: (2022)

Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M
by: Moustafa O. Aboelez, et al.
Published: (2022)

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
by: Li Y, et al.
Published: (2018)

PP 3.16 - 00209 Prolonged persistence of HIV-infected cells in tissues after allogeneic hematopoietic transplant
by: F. Maldarelli, et al.
Published: (2022)

The Immunomodulatory Effects of Albumin In Vitro and In Vivo
by: Derek S. Wheeler, et al.
Published: (2011)

The Immunomodulatory Functions of Butyrate
by: Siddiqui MT, et al.
Published: (2021)

NEW OPPORTUNITIES OF IMMUNOMODULATORY THERAPY FOR SICKLY CHILDREN
by: L.S. Namazova, et al.
Published: (2008)

NEW OPPORTUNITIES OF IMMUNOMODULATORY THERAPY FOR SICKLY CHILDREN
by: L.S. Namazova, et al.
Published: (2008)

Immunomodulatory Effects and Protection in Sepsis by the Antibiotic Moxifloxacin
by: Tiago R. Velho, et al.
Published: (2024)

Immunomodulatory Effects of Food Additives
by: Hamid Y Dar, et al.
Published: (2017)

Antileishmanial and Immunomodulatory Activity of (Garlic)
by: Masoud Foroutan-Rad MSc, et al.
Published: (2017)

Immunomodulatory Therapeutic Strategies in Stroke
by: Kyle Malone, et al.
Published: (2019)

Immunomodulatory Therapy for Rasmussen Syndrome
by: J Gordon Millichap
Published: (2013)

Alcohol: Immunomodulatory effects and cancer
by: Juan C. Molina, et al.
Published: (2023)

Antileishmanial and Immunomodulatory Activity of (Garlic)
by: Masoud Foroutan-Rad MSc, et al.
Published: (2017)

Apostillas dermatológicas: 35 Dermatologic notes: 35
by: V. Parra, et al.
Published: (2007)

PP 1.35 - 00172 A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV infected cells
by: J. Peterson, et al.
Published: (2022)

Immunomodulatory Effects of Colistin on Macrophages in Rats by Activating the p38/MAPK Pathway
by: Jin Wang, et al.
Published: (2019)

Immunomodulatory effect of dimethyloxallyl glycine/nanosilicates-loaded fibrous structure on periodontal bone remodeling
by: Zi-Qi Liu, et al.
Published: (2021)

The possibility of using antiviral drugs with immunomodulatory effects in treating HPV-associated diseases
by: El R Dovletkhanova, et al.
Published: (2014)

P 4.2 - 00029 Innate Immune Correlates of Cell-Associated HIV RNA And DNA During Long-Term Suppressive ART
by: C.-Y. Lau, et al.
Published: (2022)

Bacterial Natural Compounds with Anti-Inflammatory and Immunomodulatory Properties (Mini Review)
by: Jenab A, et al.
Published: (2020)

The role of immunomodulatory preparations in asthma treatment
by: Agnieszka Kaczynska, et al.
Published: (2021)

Immunomodulatory effects and mechanisms of distraction osteogenesis
by: Shude Yang, et al.
Published: (2022)

Immunomodulatory mechanisms of action of calcitriol in psoriasis
by: Suravi Raychaudhuri, et al.
Published: (2014)

Immunomodulatory nano-preparations for rheumatoid arthritis
by: Chenglong Li, et al.
Published: (2023)

Is Resveratrol a Cancer Immunomodulatory Molecule?
by: Ly Quoc Trung, et al.
Published: (2018)